Immunovant Inc share price logo

Immunovant Inc

NASDAQ: IMVT

Mid Cap

$27.04

-1.63

(-5.69%)

Live

as on

Immunovant Inc Stock Performance

as on May 8, 2026 at 5:09 am IST

  • Day's Low

    Day's High

    $26.76
    $28.80
    downward going graph

    1.04%

    Downside

    6.51%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $13.36
    $30.09
    downward going graph

    50.59%

    Downside

    11.28%

    Upside

    downward going graph

Immunovant Inc share price movements today

Previous Close
$28.67
Open
$28.73
Volume
747.7K
Day's Low - High
$26.76 - $28.80
52 Week Low - High
$13.36 - $30.09

Immunovant Inc Historical Returns

1 Month Return
+ 16.5 %
3 Month Return
+ 5.99 %
1 Year Return
+ 106.56 %
3 Year Return
+ 49.32 %
5 Year Return
+ 71.06 %

Immunovant Inc Stock Fundamentals & Key Indicators

Check Immunovant Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.7B

EPS (TTM)

-2.5998

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-486.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-69.35%

Immunovant Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunovant Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$5.7B71.06%NA0.00%
BUY$40.5B130.77%76.3212.55%
NA$32.5BNA70.895.37%
BUY$108.5B98.9%25.3835.51%
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Immunovant Inc Stock including INR - Dollar returns

The Immunovant Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Immunovant Inc investment value today

Current value as on today

₹2,16,700

Returns

₹1,16,700

(+116.7%)

Returns from Immunovant Inc Stock

₹94,813 (+94.81%)

Dollar Impact

₹21,887 (+21.89%)

Analyst Recommendation on Immunovant Inc Stock

Based on 22 analysts

BUY

95.45%

Buy

4.55%

Hold

0.00%

Sell

Based on 22 analysts, 95.45% of analysts recommend a 'BUY' rating for Immunovant Inc. Average target price of $40.29

Immunovant Inc Share Price Target

Get share price movements and forecasts by analysts on Immunovant Inc.

What analysts predicted

32.89%UPSIDE

Target Price

$40.29

Current Price

$27.04

Analyzed by

22 Analysts

Target

$40.29

Immunovant Inc target price $40.29, a slight upside of 32.89% compared to current price of $27.04. According to 22 analysts rating.

Indian Investors' Interest in Immunovant Inc Stock

Search interest for Immunovant Inc Stock has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:45% versus previous 30 day period

Immunovant Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
1
-
-
-
0
-
-
-
Gross Profit
0
0
1
0
0
0
0
0
0
0
Operating Income
-61
-61
-80
-94
-115
-114
-113
-127
-131
-114
EBITDA
-61
-61
-80
-94
-115
-114
-113
-127
-131
-108
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-58
-51
-75
-87
-109
-110
-105
-119
-125
-109
Income Tax Expense
0
0
0
0
0
0
0
0
0
1
Net Income
-58
-51
-75
-87
-109
-111
-106
-120
-126
-110
Net Profit Margin
0.00%
0.00%
-5021.27%
0.00%
0.00%
0.00%
-66530.63%
0.00%
0.00%
0.00%

Immunovant Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
-1
-1
0
0
Operating Income
-59
-108
-156
-208
-270
-438
EBITDA
-65
-108
-155
-208
-269
-437
Interest Expense
0
-
0
12
49
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-66
-107
-156
-210
-258
-412
Income Tax Expense
0
0
0
0
0
0
Net Income
-66
-107
-156
-210
-259
-413
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunovant Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-51
-75
-87
-109
-111
-106
-120
-126
-110
Operating Cash Flow
-47
-59
-76
-88
-100
-110
-117
-102
-92
Investing Cash Flow
0
0
0
0
0
0
-
-
-
Financing Cash Flow
469
1
0
0
2
450
2
24
564
Change in Cash
421
-55
-75
-87
-98
339
-115
-77
472

Immunovant Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
0
-28
-66
-107
-156
-210
-259
-413
Operating Cash Flow
-
-28
-53
-83
-106
-188
-214
-375
Investing Cash Flow
-
0
0
0
0
0
0
0
Financing Cash Flow
0
35
146
383
200
70
472
454
Change in Cash
0
6
93
299
93
-117
258
78

Global Institutional Holdings in Immunovant Inc

Funds
Holdings
Deep Track Capital, LP
5.66%
Morgan Stanley - Brokerage Accounts
2.38%
Woodline Partners LP
0.97%
FMR Inc
8.35%
State Street Corp
1.86%

Insights on Immunovant Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, IMVT stock has moved up by 106.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IMVT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IMVT has outperformed top 5 stocks with highest market-cap in its industry

About Immunovant Inc

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
OrganisationImmunovant Inc
Headquarters1000 Park Forty Plaza, Durham, NC, United States, 27713
IndustryBiotechnology
CEODr. Eric Venker M.D., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Immunovant Inc

Name

Title

Dr. Frank M. Torti M.B.A., M.D.

Executive Chairperson of the Board

Ms. Melanie Gloria B.S.N.

Chief Operating Officer

Mr. Christopher A. Van Tuyl Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Tiago M. Girao CPA

Chief Financial Officer

Ms. Julie Kirschling

Senior Vice President of Program & Alliance Management

Ms. Becky Merlina

Senior VP & Global Head of Quality

Dr. Eric Venker M.D., Pharm.D.

CEO & Director

Dr. Jay S. Stout M.S., Ph.D.

Chief Technology Officer

Ms. Christine Blodgett

Senior Vice President of Human Resources

Mr. Andy Deig M.B.A.

Senior Vice President of Strategic Finance

FAQs

What is Immunovant Inc share price today?

Immunovant Inc share price today is $27.04 as on . Immunovant Inc share today touched a day high of $28.8 and a low of $26.76.

What is the 52 week high and 52 week low for Immunovant Inc share?

Immunovant Inc share touched a 52 week high of $30.09 on and a 52 week low of $13.36 on . Immunovant Inc stock price today i.e. is trending at $27.04,which is 10.14% down from its 52 week high and 102.40% up from its 52 week low.

What is Immunovant Inc's market capitalisation today?

Immunovant Inc market capitalisation is $0.01T as on .

How to invest in Immunovant Inc Stock (IMVT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunovant Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunovant Inc Shares that will get you 0.0555 shares as per Immunovant Inc share price of $27.04 per share as on May 7, 2026 at 11:39 pm IST.

What is the minimum amount required to buy Immunovant Inc Stock (IMVT) from India?

Indian investors can start investing in Immunovant Inc (IMVT) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Immunovant Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunovant Inc share’s latest price of $27.04 as on May 7, 2026 at 11:39 pm IST, you will get 0.3698 shares of Immunovant Inc. Learn more about fractional shares .

What are the returns that Immunovant Inc has given to Indian investors in the last 5 years?

Immunovant Inc stock has given 71.06% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?